abstract |
The present invention relates to compounds of formula (I). Compounds of formula (I) are modulators of factor XII, especially factor XIIa. The compounds are inhibitors of factor XIIa and are useful as anticoagulants. Compounds of formula (I) are useful in methods of treating (or preventing) blood disorders associated with bleeding or coagulation. |